EBMLive 2026: Elevating Evidence-Based Healthcare in a Post-Pandemic World

EBMLive in partnership with The Pandemic EVIDENCE Collaboration presents Elevating Evidence-Based Healthcare in a Post-Pandemic World 

Enhancing evidence for public health emergencies

• Supporting the generation of high-quality evidence for public health emergencies.
• Fostering effective and efficient knowledge exchange for global public health emergencies.
• Inspiring policymakers and health system leaders to incorporate high-quality evidence into decision-making.
• Increasing public understanding of the benefits and harms of the use of NPIs during global health care emergencies in different environments.

Wiser evidence-based healthcare 

• Addressing the issue of overdiagnosis and the effective use of diagnostic tests. 
• Promoting value-based healthcare through identifying tests, procedures, and interventions that provide little or no net benefit or cause more harm than good.
• Production and translation of high-quality research evidence to support effective healthcare.
• Promoting sustainable, affordable healthcare that incudes 
• Clinical sustainability — care that improves outcomes and avoids harm or waste
• Economic sustainability — care that is cost-effective and financially viable for patients and systems.
• Environmental sustainability — reducing the carbon footprint, waste, and resource use of healthcare itself

Transforming the communication of health evidence and risk

• Effective communications through the media and social media for better understanding and use of evidence.
• How can patients, clinicians and policy-makers better understand and use evidence.
• Educating professionals, policy makers and the public to make better informed choices.
• Increasing healthcare practitioners' awareness of evidence-based medicine and its role in effective healthcare.

Improving the quality and dissemination of research evidence  

• Ensuring evidence is relevant, accessible and transparent - tackling issues such as publication bias, selective reporting and limited external validity trials.
• Reducing questionable research practices and conflicts of interest.
• Assessing the role of artificial intelligence in developing high-quality research evidence.
• reducing waste in research that incudes 
• Improving Study Design and Methods
• Addressing bias and confounding in research
• Transparency and reporting
• Industry and commercial influence